Target Advancement program. Targeting GPR43 in T cells as a potential treatment for Parkinson’s disease
Más información
| Fecha de publicación: | 2022 |
| Año de Inicio/Término: | 2022-2024 |
| Financiamiento/Sponsor: | Michael J. Fox Foundation |
| Rol del Usuario: | DIRECTOR(A) |
| DOI: |
021112 |
| Notas: | Michael J. Fox Foundation 021112 – Target Advancement program. Targeting GPR43 in T cells as a potential treatment for Parkinson’s disease (Principal Investigator). |